I will join HIHR. In addition to me, the following colleagues listed below, would also like to join. They will sign up separately to mark their interest in QF-sessions and receive the invite for the various online sessions. NB their names are needed to ensure only one invoice will be sent to your company.
Please mark your interest in the following 4 Quickfire sessions, preferably November 1 the latest (for planning purposes). After November 1, allocation will be based on availability.
1. Immuno-oncology spin-off company
Targeted anti-cancer therapy via engineered antigen presenting polymers
Therapeutics & Biotech, Oncode Institute
QF session: Monday 9 November 09.00 - 09.45
2. Preimure, automated antibacterial coatings to prevent implant-related infection
To progress different tuneable and bio-stable coatings that could be tailored based on patient demands.
Therapeutics & Biotech - UMC Utrecht
QF session: Monday 9 November, 12.00 - 12.45
3. Technology for drugging the ‘undruggable’ protein targets inside cells
By using our bodies own natural nanocarriers.
Therapeutics & Biotech - Utrecht Holdings
QF session: Monday 9 November 17.00 - 17.45
4. THERAtRAME, matching your drugs to patients.
Drug positioning, drug discovery optimization, clinical trial design
eHealth & Datascience - ULiège
QF session: Tuesday 10 November, 17.00 - 17.45
Please mark your interest for the additional QF-sessions, following their pitch sessions, if you want to be secured of a seat.
5. GOAL 3 - automated monitoring solutions
AI enhanced monitoring solutions for early detection of critical illness
Medtech & Diagnostics - Amsterdam AMC
QF session: Thursday 12 November 09.00 - 09.45
Prothesis in visual cortex of blind people to restore vision
MedTech & Diagnostics - KNAW
QF session: Thursday 12 November, 12.00 - 12.45
Help software for the diagnosis and rehabilitation of cognitive disorders
Therapeutics & Biotech - ULB
QF session: Thursday 12 November 17.00 - 17.45
8. River BioMedics
We develop and provide advanced human 3D cardiac models for drug discovery
Therapeutics & Biotech - UTwente
QF session: Friday 13 November 09.00 - 09.45
Point-of-care vascular access made easy
MedTech & Diagnostics - Utrecht Holdings
QF session: Friday 13 November, 12.00 - 12.45
10. XPECT-INX a bioink company
Bioinks” are materials to enable 3D-printing of cells and tissues
Therapeutics & Biotech - UGent
QF session: Friday 13 November 17.00 - 17.45
11. Gelgraft Medical
The solution towards minimally invasive breast reconstruction
Therapeutics & Biotech - UGent
QF session: Monday 16 November 09.00 - 09.45
Early screening test for Autism Spectrum Disorder
MedTech & Diagnostics - ULB
QF session: Monday 16 November, 12.00 - 12.45
The brain-on-a-chip company
Therapeutics & Biotech - TU Eindhoven
QF session: Monday 16 November 17.00 - 17.45
Thank you for completing this form. You will receive a confirmation shortly. We look forward to welcoming you to our online sessions in November.
By submitting this form, I agree to the invoicing of the participation fee a €200 for VCs, resp. €100 for Entrepreneurs (all amounts ex VAT). Only one invoice will be sent per organisation.